ArticleJournal of experimental orthopaedics2026
FIRM-P separates knee phenotype from patient context in anterior cruciate ligament-related instability: A conceptual framework integrating arthrogenic muscle inhibition as a cross-domain modifier.
Article in Journal of experimental orthopaedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Clinical reasoning after anterior cruciate ligament (ACL) injury is still often built on isolated proxies such as imaging, instrumented laxity, functional testing or patient-reported instability. These variables are clinically useful, but they are not interchangeable and do not answer the same question. The purpose of this work is to propose FIRM-P (Functional, Individual, Radiological and Mechanical instability plus patient context) as a practical conceptual framework that separates the ACL-related knee phenotype from patient-context indication, while integrating arthrogenic muscle inhibition (AMI) as a cross-domain modifier rather than as a separate instability pillar. Methods: FIRM-P has two layers. FIRM describes the knee through Functional, Individual, Radiological and Mechanical instability. P describes the patient context through performance demands, priorities and expectations, rehabilitation potential and personal modifiers. Each domain is interpreted as favourable, borderline or unfavourable. Discordant patterns do not directly produce treatment decisions; they trigger a verification loop. AMI is integrated as a mechanism that may alter the expression of Functional and Individual instability, may coexist with true ACL insufficiency and may influence the timing of elective surgery. Results: After verification, an explicit classification rule assigns the knee to one of four mutually exclusive phenotypes: low-instability/non-ACL, occult or associated-instability, compensated ACL-deficient or overt ACL-instability. Patient context is applied only after the knee has been phenotyped. A simplified decision pathway is provided in the main manuscript; the full operational 32-scenario matrix and an interactive HTML prototype that allows readers to simulate the algorithm across the 32 operational scenarios are provided as Supporting Information. Conclusions: FIRM-P is proposed as a conceptual framework, not a validated score. Its immediate value is to organize ACL-related instability reasoning into a transparent sequence: phenotype the knee, verify discordance and then apply patient context. Its future value will depend on content validation, reliability testing and prospective derivation work. Level of Evidence: Level V.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.